-
Update on treatments and vaccines against COVID-19 under development
Update on treatments and vaccines against COVID-19 under development
-
Update on treatments and vaccines against COVID-19 under development
Update on treatments and vaccines against COVID-19 under development
Supporting the rapid development and approval of effective and safe treatments for and vaccines against COVID-19 is EMA’s top priority. The Agency provides an update on therapeutics and vaccines under development against the disease.
-
The future of regulatory science in the EU
The future of regulatory science in the EU
-
The future of regulatory science in the EU
The future of regulatory science in the EU
EMA has published its Regulatory Science Strategy to 2025. The strategy provides a plan for advancing regulatory science over the next five years, covering both human and veterinary medicines.
-
Guidance to sponsors on how to manage clinical trials during the COVID-19 pandemic
Guidance to sponsors on how to manage clinical trials during the COVID-19 pandemic
-
Guidance to sponsors on how to manage clinical trials during the COVID-19 pandemic
Guidance to sponsors on how to manage clinical trials during the COVID-19 pandemic
EU authorities have published recommendations to guide sponsors on how to manage clinical trials and the people who participate in these trials, given the impact of the pandemic on European health systems.
-
COVID-19: latest updates
COVID-19: latest updates
-
COVID-19: latest updates
COVID-19: latest updates
Keep up to date with the latest information from EMA on the COVID-19 pandemic.
